Israele - ebraico - Ministry of Health

שביט יבוא יצוא בעמ - טיפוח העור

Israele - ebraico - Ministry of Health

שביט יבוא יצוא בעמ - טיפוח השיער

Israele - ebraico - Ministry of Health

שביט יבוא יצוא בעמ - טיפוח העור

Israele - ebraico - Ministry of Health

שביט יבוא יצוא בעמ - קרם לבן

Israele - ebraico - Ministry of Health

שביט יבוא יצוא בעמ - טיפוח עור הפנים

Spagna - spagnolo - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios menarini s.a. - beclometasona dipropionato; neomicina sulfato - emulsiÓn cutÁnea - 0,25 mg/ml + 7,2 mg/ml - beclometasona dipropionato 0,25 mg; neomicina sulfato 7,2 mg - beclometasona con antibióticos

Serbia - serbo - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

actavis d.o.o. beograd - sulfadiazin -

Stati Uniti - inglese - NLM (National Library of Medicine)

genpak solutions, llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide cream 0.025% and 0.1% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. hpa axis suppression, cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topical corticosteroids to children should be limited t

Germania - tedesco - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

dermapharm aktiengesellschaft (3326989) - fexofenadinhydrochlorid - filmtablette - teil 1 - filmtablette; fexofenadinhydrochlorid (28039) 180 milligramm

Germania - tedesco - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

dermapharm aktiengesellschaft (3326989) - fexofenadinhydrochlorid - filmtablette - teil 1 - filmtablette; fexofenadinhydrochlorid (28039) 120 milligramm